CD200 and Fabry disease: Along the same vein, we first identified the site of MRC that initiated ROS overproduction being SDH/complex II, a major site for electron driving production of ROS during an episode of FD condition suggesting that inhibitors for complex II may be a targeting therapy to alleviate ROS production, Ca2+ overload and the extents of apoptosis.